EUVIMEDEUVIMED entdecken
Open Access

Increased 3- O -sulfated heparan sulfate in Alzheimer’s disease brain is associated with genetic risk gene HS3ST1

Zhangjie Wang iD, Vaishali N Patel, Xuehong Song, Yongmei Xu iD, Andrea M Kaminski iD, Vivien Uyen Doan iD, Guowei Su iD, Yien Liao iD, Dylan Mah iD, Fuming Zhang iD, Vijayakanth Pagadala iD, Chunyu Wang und 5 weitere

Science Advances · 26.05.2023 · 9 (21)

DOI: 10.1126/sciadv.adf6232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 26.05.2023. Verfasst von Zhangjie Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIA NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HS3ST1 is a genetic risk gene associated with Alzheimer’s disease (AD) and overexpressed in patients, but how it contributes to the disease progression is unknown. We report the analysis of brain heparan sulfate (HS) from AD and other tauopathies using a LC-MS/MS method. A specific 3- O -sulfated HS displayed sevenfold increase in the AD group ( n = 14, P < 0.0005). Analysis of the HS modified by recombinant sulfotransferases and HS from genetic knockout mice revealed that the specific 3- O -sulfated HS is made by 3- O -sulfotransferase isoform 1 (3-OST-1), which is encoded by the HS3ST1 gene. A synthetic tetradecasaccharide (14-mer) carrying the specific 3- O -sulfated domain displayed stronger inhibition for tau internalization than a 14-mer without the domain, suggesting that the 3- O -sulfated HS is used in tau cellular uptake. Our findings suggest that the overexpression of HS3ST1 gene may enhance the spread of tau pathology, uncovering a previously unidentified therapeutic target for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMiceAnimalsChromatography, LiquidSulfatesTandem Mass SpectrometryHeparan SulfateSulfotransferasesMice, KnockoutBrain

Substanzen

SulfatesHeparan SulfateSulfotransferases

Autor:innen und Institutionen

  • Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Matrix and Morphogenesis Section, National Institute of Dental and Craniofacial Research, NIH, DHHS, Bethesda, MD 20892, USA.
  • Department of Molecular Pharmacology and Physiology, Byrd Alzheimer's Center and Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612 USA.
  • Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
  • Glycan Therapeutics Corp., 617 Hutton Street, Raleigh, NC 27606, USA.
  • Department of Biological Sciences, Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.

ORCID-Profile: Zhangjie Wang, Yongmei Xu, Andrea M Kaminski, Vivien Uyen Doan, Guowei Su, Yien Liao, Dylan Mah, Fuming Zhang, Vijayakanth Pagadala, Lars C Pedersen, Lianchun Wang, Matthew P Hoffman, Marla Gearing, Jian Liu

Förderung

  • NIGMS NIH HHS
  • NIA NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • Intramural NIH HHS

Zitieren

APA

Wang, Z., Patel, V. N., Song, X., Xu, Y., Kaminski, A. M., Doan, V. U., Su, G., Liao, Y., Mah, D., Zhang, F., Pagadala, V., Wang, C., Pedersen, L. C., Wang, L., Hoffman, M. P., Gearing, M., & Liu, J. (2023). Increased 3- O -sulfated heparan sulfate in Alzheimer’s disease brain is associated with genetic risk gene HS3ST1. Science Advances, 9(21). https://doi.org/10.1126/sciadv.adf6232

Vancouver

Wang Z, Patel VN, Song X, Xu Y, Kaminski AM, Doan VU, et al. Increased 3- O -sulfated heparan sulfate in Alzheimer’s disease brain is associated with genetic risk gene HS3ST1. Science Advances. 2023;9(21). doi:10.1126/sciadv.adf6232

BibTeX
@article{Wang2023,
  author = {Wang, Zhangjie and Patel, Vaishali N and Song, Xuehong and Xu, Yongmei and Kaminski, Andrea M and Doan, Vivien Uyen and Su, Guowei and Liao, Yien and Mah, Dylan and Zhang, Fuming and Pagadala, Vijayakanth and Wang, Chunyu and Pedersen, Lars C and Wang, Lianchun and Hoffman, Matthew P and Gearing, Marla and Liu, Jian},
  title = {Increased 3- O -sulfated heparan sulfate in Alzheimer’s disease brain is associated with genetic risk gene HS3ST1},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {21},
  doi = {10.1126/sciadv.adf6232}
}
Kostenlos starten →